MedTrace Logo

Fecal Microbiome Transplantation (FMT) for Type 1 Diabetes

NCT04124211 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-10-11

No results posted yet for this study

Summary

This study intends to reconstruct intestinal micro-ecology through fecal Microbiome transplantation (FMT) technology, to treat patients with type 1 diabetes, and combine intestinal Metagenomics and 16s rRNA sequencing technology to study the relevant mechanism of intestinal micro-ecology for the treatment of type 1 diabetes.

Conditions

Interventions

BIOLOGICAL

Fecal Microbiota Transplantation (FMT)

FMT will be performed through transendoscopic enteral tubing (TET) within one week during treatment period

Sponsors & Collaborators

  • Southern Medical University, China

    collaborator OTHER

  • The Third Affiliated Hospital of Southern Medical University

    lead OTHER_GOV

Principal Investigators

  • Jie Shen, MD · The Third Affiliated Hospital of Southern Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-25
Primary Completion
2020-03-10
Completion
2020-03-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04124211 on ClinicalTrials.gov